Welcome to Santa Cruz Biotechnology!

CLLU1 Antibodies

Santa Cruz Biotechnology, Inc. offers a broad range of CLLU1 antibodies. Select CLLU1 antibodies from several monoclonal and/or polyclonal CLLU1 antibodies listed below. View detailed CLLU1 antibody specifications by linking to the specific product blocks. Select appropriate CLLU1 antibodies for your research by isotype, epitope, applications and species reactivity. CLLU1 gene silencer products in siRNA, shRNA Plasmid and shRNA Lentiviral Particle formats are also available.

Introducing HOVERcruz™,

a unique system for rapid identification of CLLU1 Antibodies. Hover over product names in the table to see representative data for each product.

Live chat is now available! (click here)

Our live chat system is available to answer your product and ordering questions.

Also see additional CLLU1 Antibodies including, CLLU1OS

PRODUCT NAMECAT. #ISOTYPEEPITOPEAPPLICATIONSSPECIESCITATIONSRATING
CLLU1 (N-12)sc-138205rabbit IgGN-terminus (h)WB, IP, IF, ELISAhuman
CLLU1 (E-12)sc-138203rabbit IgGInternal (h)WB, IF, ELISAhuman
CLLU1OS (E-15)sc-138206rabbit IgGInternal (h)WB, IF, ELISAhuman
CLLU1OS (S-14)sc-138207rabbit IgGInternal (h)WB, IF, ELISAhuman
CLLU1OS (T-12)sc-138208rabbit IgGN-terminal (h)WB, IF, ELISAhuman

CLLU1 siRNA, shRNA Plasmid and shRNA Lentiviral Particles gene silencers include:

siRNAsshRNA PlasmidsshRNA Lentiviral ParticlesCITATIONSRANKING
CLLU1 siRNA (h): sc-95997CLLU1 shRNA Plasmid (h):
sc-95997-SH
CLLU1 shRNA (h)
Lentiviral Particles: sc-95997-V
CLLU1OS siRNA (h): sc-96183CLLU1OS shRNA Plasmid (h):
sc-96183-SH
CLLU1OS shRNA (h)
Lentiviral Particles: sc-96183-V

Chronic lymphocytic leukemia (CLL) is an incurable disease characterized by the presence of small mature lymphocytes, intense accumulation of monoclonal B cells and a characteristic CD5 and CD19 co-expression phenotype. While the clinical course of CLL can be highly variable, a CLL specific protein known as CLLU1 (chronic lymphocytic leukemia up-regulated 1) is expressed in CLL patients, with high CLLU1 expression associated with shorter overall survival. Consisting of 121 amino acids, CLLU1 has been predicted to interact with interleukin 4 receptor (IL-4R) and is encoded by a gene located on human chromosome 12. CLLU1OS (chronic lymphocytic leukemia up-regulated 1 opposite strand) is a 101 amino acid protein encoded by a gene that maps to human chromosome 12q22.